Particularly Stable Triazenes
1
= 0.18. H NMR (400 MHz, CDCl3): δ = 7.50 (ddd, J = 7.7, J =
172 (15) [C8H3F3O+], 166 (54), 159 (100) [C7H4F3N+], 145 (11)
[C7H4F3+], 100 (51) [C6H14N+], 58 (25) [C3H8N+], 43 (56) [C3H7+].
1.4 Hz, 1 H, Ar-H6), 7.47 (ddd, J = 8.1, J = 0.9 Hz, 1 H, Ar-H3),
7.39 (ddd, J = 7.2, J = 1.6 Hz, 1 H, Ar-H4), 7.14 (ddd, J = 7.4, J HR-EIMS (C15H20F3N3O): calcd. 315.1558; found 315.1556; ele-
= 1.2 Hz, 1 H, Ar-H5), 3.77 (q, J = 6.8 Hz, 4 H, 2ϫCH2), 2.57 (s,
mental analysis (C15H20F3N3O): calcd. C 57.13, H 6.39, N 13.33;
3 H, CH3), 1.30–1.23 (m, 6 H, 2ϫCH3) ppm. 13C NMR (100 MHz, found C 56.89, H 6.17, N 14.17.
CDCl3): δ = 203.89 (Cq, C=O), 149.39 (Cq, C2-Ar), 134.88 (+, C6-
(E)-1-[2-(3,3-Diisopropyltriaz-1-enyl)-3-(trifluoromethyl)phenyl]-
Ar), 131.50 (+, C4-Ar), 128.24 (+, C5-Ar), 124.85 (Cq, C1-Ar),
pentan-1-imine (14e): To a solution of compound 9e (597 mg,
2.00 mmol) in dry THF (15 mL) was added n-butyllithium (1.6
in hexane, 2.00 mL, 3.20 mmol) dropwise at 0 °C. After stirring at
room temp. for 2.5 h, no starting material could be detected via
TLC and the reaction was quenched with saturated NH4Cl solution
(7 mL). The aqueous phase was extracted with EtOAc (3ϫ30 mL),
the organic phase was washed with brine (20 mL) and dried with
Na2SO4. Column chromatography on silica (cyclohexane/ethyl ace-
tate, 1:1) yielded 570 mg (1.60 mmol, 80%) of the product. Rf (cy-
118.48 (+, C3-Ar), 48.99 (–, CH2), 41.58 (–, CH2), 32.08 (+, CO-
CH ), 14.51 (+, CH ), 11.24 (+, CH ) ppm. IR (KBr): ν = 3471
˜
3
3
3
(vw), 3065 (vw), 2977 (m) [–C–H valence], 2935 (w), 2875 (w)
[–CH3 valence], 1681 (m) [C=O], 1593 (w), 1467 (m), 1407 (m),
1352 (m) 1282 (m) [–C–N valence], 1246 (m), 1104 (m), 762 (m),
595 (w) cm–1. MS (70 eV, EI): m/z (%) = 219 (18) [M+], 147 (36)
[C8H7N2O+], 119 (11) [C8H7O+], 91 (100) [C7H7+], 77 (6) [C6H5+],
43 (12) [C2H5N+]. HR-EIMS (C12H17N3O): calcd. 219.1372; found
219.1375; elemental analysis (C12H17N3O): calcd. C 65.73, H 7.81,
N 19.16; found C 65.98, H 7.70, N 18.06.
1
clohexane/ethyl acetate, 1:1) = 0.29. H NMR (400 MHz, CDCl3):
δ = 9.26 (br.s, 1 H, NH), 7.64 (dd, J = 7.8, J = 1.0 Hz, 1 H, Ar-
H6), 7.35 (dd, J = 7.5 Hz, 1 H, Ar-H4), 7.18 (dt, J = 7.7, J = 0.5 Hz,
1 H, Ar-H5), 5.09 (sept, J = 6.8 Hz, 1 H, CH), 3.99 (sept, J =
6.6 Hz, 1 H, CH), 2.34 (t, J = 7.9 Hz, 2 H, CH2C=NH), 1.48–1.40
(m, 2 H, CH2), 1.33–1.21 (m, 2 H, CH2), 1.29 (d, J = 6.6 Hz, 6 H,
2ϫCH3), 1.27 (d, J = 6.8 Hz, 6 H, 2ϫCH3), 0.85 (t, J = 7.3 Hz, 3
H, CH3) ppm. 13C NMR (100 MHz, CDCl3): δ = 205.88 (Cq,
(E)-1-[2-(3,3-Diisopropyltriaz-1-enyl)phenyl]ethanone (13d): Follow-
ing general procedure D, compound 9d (230 mg, 1.00 mol) was
treated with MeMgBr (3 in Et2O, 1.00 mL, 1.60 mmol) in THF
(10 mL). Column chromatography (n-pentane/diethyl ether, 4:1) on
silica yielded 168 mg (0.68 mmol, 68%) of a white solid. Rf (n-pen-
tane/diethyl ether, 4:1) = 0.18. 1H NMR (400 MHz, CDCl3): δ =
7.51 (ddd, J = 7.7, J = 1.1 Hz, 1 H, Ar-H6), 7.47 (ddd, J = 8.2, J C=NH), 135.38 (Cq, C2-Ar), 134.66 (+, C1-Ar), 132.06 (+, C6-Ar),
= 1.2, J = 0.8 Hz, 1 H, Ar-H3), 7.39 (ddd, J = 7.1, J = 1.5 Hz, 1
H, Ar-H4), 7.13 (ddd, J = 7.7, J = 1.2, J = 0.5 Hz, 1 H, Ar-H5),
5.25 (br.s, 1 H, CH), 4.02 (br.s, 1 H, CH), 2.57 (s, 3 H, CH3), 1.39
(d, J = 4.8 Hz, 6 H, 2ϫCH3), 1.26 (bd, 6 H, 2ϫCH3) ppm. 13C
126.68 (+, q, C4-Ar, J = 5.6 Hz), 124.04 (+, q, CF3, J = 273.5 Hz),
123.88 (+, q, CCF3, J = 29.7 Hz), 123.77 (+, C5-Ar), 50.11 (+,
CH), 47.00 (+, CH), 39.48 (–, CH2C=NH), 28.42 (–, CH2), 23.34
(+, 2ϫCH3), 22.45 (–, CH2), 19.15 (+, 2ϫCH3), 13.83 (+, CH3).
NMR (100 MHz, CDCl3): δ = 204.01 (Cq, C=O), 150.00 (Cq, C2- 19F NMR (376 MHz, CDCl3): δ = –59.4 (m, CF3) ppm. IR (KBr):
Ar), 134.73 (+, C6-Ar), 131.45 (+, C4-Ar), 128.48 (+, C5-Ar),
ν = 2972 (m) 2934 (m) [–C–H valence], 2873 (w), 1691 (w) [C=NH],
124.53 (Cq, C1-Ar), 118.49 (+, C3-Ar), 49.16 (+, CH), 41.58 (–, 1626 (w), 1584 (w), 1405 (s), 1315 (m), 1229 (m) [–C–N valence],
˜
CH2), 46.68 (+, CH), 32.21 (+, CO-CH3), 23.92 (+, CH3), 19.41
1134 (s) [CF3], 1032 (w), 775 (w), 753 (w) cm–1. MS (70 eV, EI):
(+, CH ) ppm. IR (KBr): ν = 3335 (w), 3067 (m), 2977 (m) [–C–H m/z (%) = 356 (28) [M+], 299 (26) [C14H18F3N4+], 285 (9)
˜
3
valence], 1952 (w), 1923 (w), 1676 (m) [C=O], 1591 (m), 1472 (m), [C14H18F3N3 + ], 243 (100) [C11H12F3N3+], 228 (14) [C12H13F3N+],
1403 (s), 1368 (m), 1285 (m) [–C–N valence], 1238 (m), 1220 (m), 223 (28), 208 (11), 201 (42) [C11H13N4+], 200 (38) [C8H5F3N3+],
1156 (m), 753 (m) cm–1. MS (70 eV, EI): m/z (%) = 247 (15) [M+],
188 (10) [C10H12N4+], 187 (13) [C10H11N4+], 173 (37) [C7H4F3N2+],
147 (15) [C8H7N2O+], 120 (9) [C8H7O+], 119 (25) [C8H7O+], 105 172 (81) [C8H5F3N+], 166 (17), 145 (12) [C7H4F3+], 100 (16)
(27) [C7H5O+], 100 (36) [C6H14N+], 92 (8), 91 (100) [C6H5N+], 77
(6) [C6H5+], 58 (6) [C3H8N+], 43 (20) [C3H7+]. HR-EIMS
(C14H21N3O): calcd. 247.1685; found 247.1683; elemental analysis
(C14H21N3O): calcd. C 67.98, H 8.56, N 16.99; found C 67.62, H
8.34, N 16.93.
[C6H14N+], 84 (12) [C5H10N+], 58 (16) [C3H8N+], 43 (52) [C3H7+].
HR-EIMS (C18H27F3N4): calcd. 356.2188; found 356.2186.
(E)-[2-(3,3-Diisopropyltriaz-1-enyl)-3-(trifluoromethyl)phenyl]-
(phenyl)methanimine (16e): To a solution of compound 9e (597 mg,
2.00 mol) in dry THF (15 mL) was added phenyllithium (2.0 in
(E)-1-[2-(3,3-Diisopropyltriaz-1-enyl)-3-(trifluoromethyl)phenyl]- dibutyl ether, 1.60 mL, 3.20 mmol) dropwise at 0 °C. After stirring
ethanone (13e): Following general procedure D, compound 9e
(597 mg, 2.00 mmol) was treated with MeMgBr (3 in Et2O,
2.00 mL, 3.20 mmol) in THF (15 mL). Column chromatography on
at room temp. for 2.5 h, no starting material could be detected via
TLC and the reaction was quenched with saturated NH4Cl solution
(7 mL). The aqueous phase was extracted with EtOAc (3ϫ30 mL),
silica (n-pentane/diethyl ether, 3:1) yielded 493 mg (1.56 mmol, the organic phase was washed with brine (20 mL) and dried with
1
78%) of a white solid. Rf (n-pentane/diethyl ether, 3:1) = 0.35. H
NMR (400 MHz, CDCl3): δ = 7.65 (dd, J = 7.8, J = 0.9 Hz, 1 H,
Ar-H6), 7.40 (dd, J = 7.1 Hz, 1 H, Ar-H4), 7.18 (dt, J = 7.7, J =
0.6 Hz, 1 H, Ar-H5), 5.13 (sept, J = 6.8 Hz, 1 H, CH), 4.00 (sept,
J = 6.6 Hz, 1 H, CH), 2.12 (s, 3 H, CH3), 1.31 (d, J = 6.6 Hz, 6
H, 2ϫCH3), 1.28 (d, J = 6.8 Hz, 6 H, 2ϫCH3) ppm. 13C NMR
(100 MHz, CDCl3): δ = 202.46 (Cq, C=O), 179.29 (Cq, C2-Ar),
Na2SO4. Column chromatography on silica (cyclohexane/ethyl ace-
tate, 3:1) yielded 734 mg (1.95 mmol, 95%) of the product. Rf (cy-
clohexane/ethyl acetate, 1:1) = 0.56. H NMR (400 MHz, CDCl3):
δ = 9.52 (br.s, 1 H, NH), 7.73 (dd, J = 7.8, J = 1.0 Hz, 1 H, Ar-
H4), 7.62 (d, J = 7.3 Hz, 2 H, Aro-H), 7.42 (d, J = 7.5 Hz, 1 H,
Arp-H), 7.39–7.35 (m, 1 H, Ar-H6), 7.33–7.28 (m, 2 H, Arm-H) 7.23
(dt, J = 7.7, J = 0.5 Hz, 1 H, Ar-H5), 4.63 (sept, J = 6.8 Hz, 1 H,
1
131.62 (+, C6-Ar), 128.02 (+, J = 5.4 Hz, q, C4-Ar), 126.77 (+, q, CH), 3.77 (sept, J = 6.6 Hz, 1 H, CH), 1.03 (d, J = 6.7 Hz, 6 H,
C1-Ar, J = 5.4 Hz), 124.08 (+, q, CCF3, J = 29.8 Hz), 124.03 (+, 2ϫCH3), 1.00 (d, J = 6.8 Hz, 6 H, 2ϫCH3) ppm. 13C NMR
q, CF3, J = 273.5 Hz), 123.82 (+, C5-Ar), 50.11 (+, CH), 47.15
(100 MHz, CDCl3): δ = 177.33 (Cq, C=NH), 148.22 (Cq, C2-Ar),
(+, CH), 23.42 (+, COCH3), 19.18 (+, 4ϫCH3) ppm. 19F NMR 137.75 (+, Ci-Ar), 133.38 (+, Co-Ar), 133.05 (+, C6-Ar), 130.24 (+,
(376 MHz, CDCl ): δ = –58.2 (m, CF ) ppm. IR (KBr): ν = 2976
Cp-Ar), 128.08 (+, C1-Ar), 127.99 (+, Cm-Ar), 127.08 (+, J =
5.5 Hz, q, C4-Ar), 124.07 (+, q, CF3, J = 273.5 Hz), 124.00 (+, q,
CCF3, J = 29.6 Hz), 123.64 (+, C5-Ar), 50.47 (+, CH), 47.18 (+,
˜
3
3
(w), 2935 (w), 1694 (w) [C=O], 1629 (w), 1583 (w), 1405 (m), 1368
(m), 1312 (s), 1229 (m) [–C–N valence], 1133 (s) [CF3] cm–1. MS
(70 eV, EI): m/z (%) = 315 (18) [M+], 215 (8) [C9H6F3N2O+], 201
CH), 22.81 (+, CH ), 18.71 (+, CH ) ppm. IR (KBr): ν = 2975 (m),
˜
3
3
(39) [C9H6F3NO+], 187 (28) [C9H6F3O+], 173 (22) [C7H4F3N2+], 2935 (w) [–C–H valence], 1603 (w) [C=NH], 1405 (s), 1367 (m),
Eur. J. Org. Chem. 2008, 3314–3327
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
3323